Search

everythinglearnresearchcommunity

for

Search:↓

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Ritlecitinib effectively treats alopecia areata with manageable side effects.

New skin treatments in 1987-1988 showed effectiveness for various conditions, but some had side effects or risks.

BMS-470539 reduces skin fibrosis and inflammation.

Spanlastic-laden nanogel could be a better way to deliver hair growth medication through the skin for treating hair loss.

Ponatinib can cause a rare skin reaction that resolves with topical treatment and temporary drug discontinuation.

Topical Flutamide 1% gel effectively and safely reduces acne.

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Retinol with polylysine cleared scalp skin growths in 21 days without side effects.

The new gel effectively treats scalp and beard fungal infections with fewer side effects.

The cream with xyloglucan, pea protein, and cactus extract works as well as the standard treatment for psoriasis and is well-tolerated.

Ingenol mebutate gel changes gene expression related to skin development and immune response in actinic keratosis.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib helps keep hair, eyebrows, and eyelashes regrown for 3 years in most people with severe hair loss.

Baricitinib was effective in treating both early and late onset alopecia areata.

The new gel formulation effectively delivers Finasteride for hair growth treatment without skin irritation.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

Long-term baricitinib treatment can lead to significant scalp hair regrowth in patients initially showing only eyebrow or eyelash regrowth.

Dapsone gel 5% is effective and safe for treating acne.

The new gel with Zinc Oxide nanoparticles and finasteride shows promise for treating hair loss when applied to the skin.

Ritlecitinib is effective and safe for long-term use in treating severe alopecia areata in people aged 12 and older.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

The synthetic retinoid EC23 thickens skin and promotes hair growth more effectively and with a lower dose than natural retinoids.